A detailed history of Flaharty Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Flaharty Asset Management, LLC holds 2,415 shares of BMY stock, worth $138,451. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,415
Holding current value
$138,451
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$39.66 - $51.75 $95,778 - $124,976
2,415 New
2,415 $124,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $636 - $712
11 Added 0.28%
3,884 $225,000
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $246,748 - $273,976
3,873 New
3,873 $247,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Flaharty Asset Management, LLC Portfolio

Follow Flaharty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flaharty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flaharty Asset Management, LLC with notifications on news.